We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI'... Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests. Show more
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY, April 25, 2024 SALT LAKE CITY, April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan PR Newswire SALT LAKE CITY, April 24, 2024 SALT LAKE CITY, April 24, 2024 /PRNewswire/ -- Co-Diagnostics...
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event PR Newswire SALT LAKE CITY, April 12, 2024 Ribbon-cutting included support from Mayor Wood of South...
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions PR Newswire SALT LAKE CITY, April 4, 2024 SALT LAKE CITY, April 4, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX...
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address PR Newswire SALT LAKE CITY, March 21, 2024 Presentation included announcement of the...
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England PR Newswire SALT LAKE CITY, Utah, March 18, 2024 SALT LAKE CITY, Utah, March 18, 2024 /PRNewswire/...
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results PR Newswire SALT LAKE CITY, March 14, 2024 SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a...
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test PR Newswire SALT LAKE CITY, March 7, 2024 The clinical laboratory real-time PCR multiplex...
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY, Feb. 29, 2024 SALT LAKE CITY, Feb. 29, 2024 /PRNewswire/...
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 PR Newswire SALT LAKE CITY, Feb. 1, 2024 SALT LAKE CITY, Feb. 1, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 2.7027027027 | 1.11 | 1.185 | 1.091 | 60951 | 1.15603018 | CS |
4 | 0.05 | 4.5871559633 | 1.09 | 1.29 | 1.0689 | 61237 | 1.17326471 | CS |
12 | -0.11 | -8.8 | 1.25 | 1.29 | 1.02 | 57415 | 1.15230165 | CS |
26 | 0.06 | 5.55555555556 | 1.08 | 1.6567 | 1.02 | 84626 | 1.25731837 | CS |
52 | -0.26 | -18.5714285714 | 1.4 | 1.89 | 0.975 | 92313 | 1.272923 | CS |
156 | -7.85 | -87.319243604 | 8.99 | 11.82 | 0.975 | 389377 | 7.07584926 | CS |
260 | 0.08 | 7.54716981132 | 1.06 | 31.4 | 0.694 | 1607116 | 11.1129231 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions